Marshall Wace
HBIO icon

Marshall Wace’s Harvard Bioscience HBIO Stock Holding History

Marshall Wace’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,870
Closed -$61K – 3077
2025
Q2 		$61K Buy
+13,870
New +$58K ﹤0.01% 2583
2023
Q3 		– Sell
-5,465
Closed -$300K – 2401
2023
Q2 		$300K Buy
+5,465
New +$300K ﹤0.01% 2142
2022
Q4 		– Sell
-7,692
Closed -$196K – 3126
2022
Q3 		$196K Buy
7,692
+2,355
+44% +$77.9K ﹤0.01% 3089
2022
Q2 		$192K Buy
+5,337
New +$241K ﹤0.01% 3175
2021
Q3 		– Sell
-2,928
Closed -$244K – 3182
2021
Q2 		$244K Buy
2,928
+268
+10% +$19K ﹤0.01% 2389
2021
Q1 		$145K Buy
+2,660
New +$129K ﹤0.01% 2321
2020
Q1 		– Sell
-14,214
Closed -$434K – 1816
2019
Q4 		$434K Sell
14,214
-18,331
-56% -$527K ﹤0.01% 1207
2019
Q3 		$1M Sell
32,545
-8,740
-21% -$217K 0.01% 946
2019
Q2 		$826K Buy
41,285
+32,631
+377% +$956K 0.01% 980
2019
Q1 		$373K Buy
8,654
+7,409
+595% +$269K ﹤0.01% 1215
2018
Q4 		$40K Sell
1,245
-1,105
-47% -$43.6K ﹤0.01% 1471
2018
Q3 		$123K Buy
+2,350
New +$132K ﹤0.01% 1095

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's HBIO Position: Q3 2025 in Review

Marshall Wace sold out of Harvard Bioscience (HBIO) in Q3 2025, closing a stake of 13,870 shares — an estimated $61K sold.

Marshall Wace first reported a position in HBIO in Q3 2018 and held it in 12 quarters. The position peaked at $1M in Q3 2019. 59 funds tracked by Wall St. Rank hold HBIO as of Q3 2025.

  • Marshall Wace reported no remaining Harvard Bioscience position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 13,870 Harvard Bioscience shares in Q3 2025, an estimated $61K.
  • Marshall Wace first reported a position in Harvard Bioscience in Q3 2018 and held it in 12 quarters.
  • Marshall Wace's Harvard Bioscience position peaked at $1M in Q3 2019.
  • 59 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.